Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
- PMID: 16169466
- DOI: 10.1016/j.ccr.2005.08.002
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
Abstract
Bone marrow-derived cells contribute to tumor angiogenesis. Here, we demonstrate that monocytes expressing the Tie2 receptor (Tie2-expressing monocytes [TEMs]) (1) are a distinct hematopoietic lineage of proangiogenic cells, (2) are selectively recruited to spontaneous and orthotopic tumors, (3) promote angiogenesis in a paracrine manner, and (4) account for most of the proangiogenic activity of myeloid cells in tumors. Remarkably, TEM knockout completely prevented human glioma neovascularization in the mouse brain and induced substantial tumor regression. Besides TEMs and endothelial cells (ECs), Tie2 expression distinguished a rare population of tumor stroma-derived mesenchymal progenitors representing a primary source of tumor pericytes. Therefore, Tie2 expression characterizes three distinct cell types required for tumor neovascularization: ECs, proangiogenic cells of hematopoietic origin, and pericyte precursors of mesenchymal origin.
Similar articles
-
Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.Nat Med. 2003 Jun;9(6):789-95. doi: 10.1038/nm871. Epub 2003 May 12. Nat Med. 2003. PMID: 12740570
-
Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.Cancer Res. 2010 Jul 1;70(13):5270-80. doi: 10.1158/0008-5472.CAN-10-0012. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530679
-
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.Blood. 2007 Jun 15;109(12):5276-85. doi: 10.1182/blood-2006-10-053504. Epub 2007 Feb 27. Blood. 2007. PMID: 17327411
-
Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications.Trends Immunol. 2007 Dec;28(12):519-24. doi: 10.1016/j.it.2007.09.004. Epub 2007 Nov 5. Trends Immunol. 2007. PMID: 17981504 Review.
-
Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy?Biochim Biophys Acta. 2009 Aug;1796(1):5-10. doi: 10.1016/j.bbcan.2009.04.001. Epub 2009 Apr 10. Biochim Biophys Acta. 2009. PMID: 19362584 Review.
Cited by
-
Angiopoietin-1 facilitates recovery of hematopoiesis in radiated mice.Am J Transl Res. 2016 May 15;8(5):2011-21. eCollection 2016. Am J Transl Res. 2016. PMID: 27347310 Free PMC article.
-
The role of tumor-associated macrophages in primary hepatocellular carcinoma and its related targeting therapy.Int J Med Sci. 2021 Mar 15;18(10):2109-2116. doi: 10.7150/ijms.56003. eCollection 2021. Int J Med Sci. 2021. PMID: 33859517 Free PMC article. Review.
-
NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.Oncoimmunology. 2015 Jan 22;4(4):e1001204. doi: 10.1080/2162402X.2014.1001204. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26137396 Free PMC article.
-
Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.Biomed Res Int. 2015;2015:974615. doi: 10.1155/2015/974615. Epub 2015 Mar 25. Biomed Res Int. 2015. PMID: 25883982 Free PMC article.
-
Microenvironmental modulation of the developing tumour: an immune-stromal dialogue.Mol Oncol. 2021 Oct;15(10):2600-2633. doi: 10.1002/1878-0261.12773. Epub 2020 Aug 28. Mol Oncol. 2021. PMID: 32741067 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous